U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
113491113491Head and Neck Cancer Registry (LORHAN)CompletedNo Results AvailableHead and Neck CancerOther: Therapy for head and neck cancerhttps://ClinicalTrials.gov/show/NCT01080313
113492113492Breeze3:Study of Gabapentin Extended Release in the Treatment of Vasomotor Symptoms(Hot Flashes)in Postmenopausal WomenCompletedHas ResultsHot FlashesDrug: Gabapentin Extended Release|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01080300
113493113493The Identification and Characterization of Autonomic Dysfunction in Migraineurs With and Without AurasCompletedNo Results AvailableMigrainehttps://ClinicalTrials.gov/show/NCT01080287
113494113494Vitamin D and Zinc Levels in Patients Undergoing Ergometry TestActive, not recruitingNo Results AvailableAtherosclerosishttps://ClinicalTrials.gov/show/NCT01080274
113495113495PROMUS Element Japan Small Vessel TrialActive, not recruitingHas ResultsAtherosclerosis|Coronary Artery DiseaseDevice: PROMUS Elementhttps://ClinicalTrials.gov/show/NCT01080261
113496113496Gemcitabine and Pazopanib in Metastatic Pancreatic CancerTerminatedHas ResultsPancreatic CancerDrug: Gemcitabine|Drug: Pazopanibhttps://ClinicalTrials.gov/show/NCT01080248
113497113497Improving Quality of Care for Elderly Patients in the Educational SettingCompletedNo Results AvailableElderlyOther: ABIM Care of Vulnerable Elderly Practice Improvement Module|Other: Geriatric and Quality Improvement toolkithttps://ClinicalTrials.gov/show/NCT01080235
113498113498A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus InfectionTerminatedNo Results AvailableChronic Hepatitis C Virus InfectionDrug: telaprevir|Drug: VX-222|Drug: ribavirin|Biological: peginterferon-alfa-2a|Drug: VX-222https://ClinicalTrials.gov/show/NCT01080222
113499113499Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery SystemCompletedHas ResultsPatients Who Participated in an Intravitreal Brimo PS DDS® StudyDrug: Brimo PS DDS®|Other: Shamhttps://ClinicalTrials.gov/show/NCT01080209
113500113500Reducing Falls With RENEW in Older Adults Who Have FallenRecruitingNo Results AvailableMuscle Atrophy|FallsOther: RENEW vs TRADhttps://ClinicalTrials.gov/show/NCT01080196
113501113501Functional Assessment Screening Tablets - Patient Reported MeasuresCompletedNo Results AvailableSmokingOther: Patient feedback formhttps://ClinicalTrials.gov/show/NCT01080183
113502113502The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast CancerCompletedNo Results AvailableBreast Cancerhttps://ClinicalTrials.gov/show/NCT01080170
113503113503Evaluation of a Noninvasive Diabetes Screening Device in Subjects at Risk for DiabetesCompletedNo Results AvailableDiabetesDevice: SCOUT DS measurementhttps://ClinicalTrials.gov/show/NCT01080157
113504113504Feasibility of Critical Flicker Frequency Procedure for the Diagnosis of Minimal EncephalopathyCompletedNo Results AvailableCirrhosisOther: Critical flicker frequency procedurehttps://ClinicalTrials.gov/show/NCT01080144
113505113505Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study.CompletedHas ResultsAcute GoutDrug: Canakinumab 150 mg|Drug: Triamcinolone acetonide 40 mg|Drug: Placebo to canakinumab|Drug: Placebo to triamcinolone acetonidehttps://ClinicalTrials.gov/show/NCT01080131
113506113506Effectiveness of Video System in Improving Learning of Tracheal Intubation Using Standard Laryngoscopy Among NovicesCompletedHas ResultsIntubation IntraesophagealDevice: Airtraq|Other: Control group, taught with a standard Macintosh laryngoscopehttps://ClinicalTrials.gov/show/NCT01080118
113507113507Internet Intervention for the Prevention of Depression - Approaches to Improving MoodWithdrawnNo Results AvailableIndividuals at Risk for DepressionBehavioral: AIM Web based intervention + surveillance|Behavioral: AIM web based intervention|Behavioral: Educational websitehttps://ClinicalTrials.gov/show/NCT01080105
113508113508Effect of Stress-management and Biofeedback on Craving in Smoking Abstinence: A Pilot StudyCompletedNo Results AvailableSmoking CessationBehavioral: breathing technique|Behavioral: behavioral strategieshttps://ClinicalTrials.gov/show/NCT01080092
113509113509Efficacy and Safety Study of Iontophoretic Application of Terbinafine Gel in Subjects With OnychomycosisCompletedNo Results AvailableOnychomycosisDrug: Terbinafine Hydrochloride|Other: Purified Waterhttps://ClinicalTrials.gov/show/NCT01080079
113510113510A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN)CompletedNo Results AvailableCarcinoma, Squamous Cell of Head and NeckOther: No Interventionhttps://ClinicalTrials.gov/show/NCT01080066
113511113511Sexual Dysfunction, Disability and Quality of Life in Patients With Multiple Sclerosis (MS)CompletedNo Results AvailableMultiple Sclerosis, Relapsing Remittinghttps://ClinicalTrials.gov/show/NCT01080053
113512113512To Assess the Prevalence of Spasticity and the Impact on the Quality of Life in Multiple Sclerosis PatientsCompletedNo Results AvailableMultiple Sclerosis, Relapsing Remittinghttps://ClinicalTrials.gov/show/NCT01080040
113513113513Safety, Tolerability and Adherence With Rebif® New Formulation in Real Life Settings (STAR)CompletedNo Results AvailableMultiple Sclerosis, Relapsing RemittingDrug: Rebif® New Formulationhttps://ClinicalTrials.gov/show/NCT01080027
113514113514Correlation Between Multiple Sclerosis Functional Composite (MSFC) and Expanded Disability Status Scale (EDSS) in Patients With Multiple Sclerosis (MS) in ArgentinaCompletedNo Results AvailableMultiple Sclerosishttps://ClinicalTrials.gov/show/NCT01080014
113515113515A Observational, Prospective Study to Assess the Impact of Fatigue in the Quality of Life of Patients With Multiple Sclerosis in ArgentinaCompletedNo Results AvailableMultiple Sclerosis, Relapsing-remittinghttps://ClinicalTrials.gov/show/NCT01080001
113516113516Study of Therapeutic Options for Subjects Discontinuing Efalizumab and Experiencing Disease RecurrenceCompletedHas ResultsPsoriasisDrug: Cyclosporins|Drug: Retinoids|Drug: Systemic corticosteroids|Drug: Methotrexate|Drug: Systemic corticosteroids/methotrexatehttps://ClinicalTrials.gov/show/NCT01079988
113517113517To Identify and Evaluate the Predictive Factors for Depression in Patients Diagnosed With Multiple SclerosisCompletedNo Results AvailableMultiple Sclerosishttps://ClinicalTrials.gov/show/NCT01079975
113518113518An Active-controlled, Clinical Trial to Assess Central Hemodynamic Effects of Bisoprolol in Hypertensive Patients (Central Hemodynamic Assessment Measured in Patient With HypertensION [CHAMPION])CompletedHas ResultsHypertensionDrug: Bisoprolol|Drug: Atenololhttps://ClinicalTrials.gov/show/NCT01079962
113519113519A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive AgeTerminatedHas ResultsInfertility|Ovulation InductionDrug: r-hLH + r-hFSH|Drug: r-hFSH|Drug: Recombinant Human Choriogonadotropin (r-hCG)|Drug: GnRH antagonisthttps://ClinicalTrials.gov/show/NCT01079949
113520113520Lenalidomide and High-Dose MelphalanCompletedNo Results AvailableMyeloma|Stem Cell TransplantationDrug: Lenalidomide|Drug: Melphalan|Procedure: Stem Cell Infusionhttps://ClinicalTrials.gov/show/NCT01079936

* Görseller ve İçerik tekif hakkına sahip olabilir